" data-display-label="0" data-show-count="1" data-bookmark-label="Save" data-bookmarked-label="Saved" data-loggedin="0" data-type="post" data-object_id="320372" class="cbxwpbkmarktrig ...

" data-display-label="0" data-show-count="1" data-bookmark-label="Save" data-bookmarked-label="Saved" data-loggedin="0" data-type="post" data-object_id="320295" class="cbxwpbkmarktrig ...

The Star’s former CEO has told a court he thought a general counsel was “painting very dramatic pictures” when he voiced concerns about cash transactions in junket operator Suncity’s VIP room.

The Supreme Court of Victoria has been urged not to meddle with a 25 per cent group costs order in a junk insurance class action that settled for $170 million, in what would be the court’s second ...

Transgrid contractor Elecnor unlawfully denied the Electrical Trades Union access to 47 migrant workers on Australia’s largest transmission project, a court has found.

Are group costs orders a factor in deciding a bid to transfer a class action? Can the orders survive the move to an inhospitable state? These questions are to be decided by the High Court Wednesday, ...

Mayfield Development is barred from bringing claims already traversed in a competition case by the ACCC that was thrown out by a court, NSW Ports has told an appeals court.

" data-display-label="0" data-show-count="1" data-bookmark-label="Save" data-bookmarked-label="Saved" data-loggedin="0" data-type="post" data-object_id="319398" class="cbxwpbkmarktrig ...

Fonterra, which has taken cheese maker Bega to court to resolve a dispute over the dairy company’s plans to exit the Australian market, is resisting a bid for discovery in the case.

Fonterra, which has taken cheese maker Bega to court to resolve a dispute over the dairy company’s plans to exit the Australian market, is resisting a bid for discovery in the case.

The High Court won’t hear Bayer’s appeal of an invalidity finding over patents for blood thinner Xarelto, despite the company’s claim the decision has “profound” consequences for drug R&D.

Star Entertainment has reached an agreement with Hong Kong-based investors Chow Tai Fook Enterprises and Far East Consortium on the $53 million buyout of its stake in the Queen’s Wharf entertainment ...